Lamotrigine Relonchem

Lamotrigine, the active ingredient in Lamotrigine Relonchem, is an antiepileptic presented as an oral tablet for oral use. It treats epilepsy, helps stabilize mood in bipolar disorder, and is used to prevent migraine in adult patients.\n\nGNH India supplies Lamotrigine Relonchem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an antiepileptic drug that acts on neuronal excitability across several neurological and psychiatric conditions.\n\nEpilepsy: reduces the frequency of partial and generalized seizures.\nBipolar disorder: helps maintain mood stability and prevents depressive and manic episodes.\nPrevention of migraine: decreases the occurrence of migraine attacks in adults.

Lamotrigine may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Skin rash or itching.\n- Headache.\n- Dizziness or light‑headedness.\n- Nausea or vomiting.\n- Fatigue or drowsiness.\n- Tremor.\n\nSerious or Rare Side Effects:\n- Stevens‑Johnson syndrome or toxic epidermal necrolysis.\n- Severe allergic reactions (anaphylaxis).\n- Blood dyscrasias such as agranulocytosis.\n- Hepatic dysfunction.\n- Aseptic meningitis.\n- Suicidal thoughts or behavior.

Before initiating lamotrigine therapy, consider the following safety measures.\n\nPregnancy: risk to fetus is unknown; discuss benefits and risks with a healthcare professional.\nBreastfeeding: lamotrigine is excreted in breast milk; evaluate infant exposure.\nDrug interactions: review concomitant medications for potential interactions.\nRenal or hepatic impairment: dose adjustment may be required.\nSkin reactions: discontinue immediately if a severe rash develops.\nStore at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Lamotrigine can interact with several medicines, altering its effectiveness or safety profile.\n\nMajor Interactions (Avoid):\n- Valproic acid: markedly increases lamotrigine plasma levels, risk of toxicity.\n- Carbamazepine, phenytoin, phenobarbital: reduce lamotrigine concentrations, may diminish efficacy.\n\nModerate Interactions (Monitor Closely):\n- Oral contraceptives: may lower lamotrigine levels, requiring dose adjustment.\n- Serotonergic agents: potential for increased risk of serotonin syndrome.\n- Other antiepileptics (e.g., levetiracetam): may require therapeutic monitoring.